ESC Premium Access

Atheroprotective effects of ticagrelor, a P2Y12 antagonist, in apolipoprotein-E-deficient mice

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Congress Presentation

About the speaker

Doctor Byambasuren Ganbaatar

Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima (Japan)
0 follower

7 more presentations in this session

Adiponectin forms a complex with electronegative L5 LDL in human plasma and inhibits its atherogenic effects

Speaker: Professor T. Sawamura (Matsumoto, JP)

Thumbnail

Magnetic drug targeting to vascular injury regions and atherosclerotic lesions: in vivo pilot study

Speaker: Doctor I. Cicha (Erlangen, DE)

Thumbnail

Nicotine promotes atherosclerosis development in apolipoprotein E-deficient mice through alpha 1 nicotinic acetylcholine receptor on RAW264.7 and MOVAS cells

Speaker: Mr A. Ren (Shanghai, CN)

Thumbnail

miR-147 deficiency in macrophages exacerbates atherosclerosis in mice

Speaker: Mrs M. Nazari Jahantigh (Munich, DE)

Thumbnail

Deletion of cyclophilin d inhibits atherosclerotic plaque formation in apolipoprotein-e deficient mice

Speaker: Doctor R. Umezu (Fukuoka, JP)

Thumbnail

Access the full session

Poster Session 4 - Inflammation and microcirculation

Speakers: Doctor B. Ganbaatar, Professor T. Sawamura, Doctor I. Cicha, Mr A. Ren, Mrs M. Nazari Jahantigh...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb